Interventional Products

Sanovas Business Units

Sanovas’ commercial business is segmented into business units that leverage cost-effective delivery of the diagnostic and therapeutic interventions enabled by our core micro technology platforms. Each business unit focuses on a specific target audience.

Imaging Technologies

Sanovas Imaging Technologies products provide excellent in-situ visualization, advanced imaging, unprecedented working capabilities in small anatomic spaces, and dramatic reduction of endoscopy and other imaging related costs. These products reduce visualization costs in hospitals and healthcare facilities by up to 5X while safely and predictably expanding the use of minimally invasive diagnostic and therapeutic interventions for a range of specialists. These benefits are made possible because:

  • Proprietary MicroCam™ Imaging sensor-based technology dramatically reduces instrument size and production costs.

  • Multifunctional optical engineering and design enables cameras to be deployed on a broad range of universal devices and micro-instruments in the visible and non-visible spectrum.

  • Optical miniaturization enables diagnosis and therapy delivery in previously inaccessible and distal anatomies.

  • Dramatically reduced imaging and endoscopy-related costs expand access to advanced technology for millions of hospitals and healthcare providers worldwide.

  • Imaging in the non-visible spectrum enables sophisticated diagnostic and therapeutic interventions.

Interventional Lung

Sanovas Interventional Lung products provide interventional pulmonologists with minimally invasive, localized diagnostic and therapeutic interventions for a range of pulmonary pathologies. These products safely provide access, visualization, and measurement to expand physicians’ capabilities to diagnose and treat in previously inaccessible airways. The Sanovas Interventional Lung portfolio provides hospitals and healthcare facilities with significant reductions in cost compared to conventional technologies. These benefits are made possible because Sanovas Interventional Lung products:

  • Safely enable access and in-situ visualization in previously inaccessible airways.

  • Provide large, steerable, and stable working channels and simultaneous multi-instrument, multi-modal diagnostic and therapeutic interventions in small anatomies.

  • Make in-vivo local diagnostic and therapeutic interventions safe and predictable in peripheral anatomical sites below 3mm.

  • Dramatically reduce the cost of imaging, diagnostic, and therapeutic interventions.

Interventional ENT

Sanovas Interventional ENT products provide otolaryngologists with minimally invasive, localized diagnostic and therapeutic interventions for a range of ENT pathologies. These products safely provide access, imaging, and measurement to expand physicians’ capabilities to diagnose and treat in challenging anatomies and enable the site of care to shift to convenient and lower cost settings. These benefits are made possible because Sanovas Interventional ENT products:

  • Safely enable access and visualization in previously inaccessible sites and small cavities below 3mm.

  • Provide stable, steerable working channels and simultaneous multi-instrument, multi-modal diagnostic and therapeutic interventions in small anatomies.

  • Dramatically reduce the cost of visualization, diagnostic, and therapeutic interventions.

Interventional Uro & Gyn

Sanovas Interventional Uro & Gyn products provide urologists, gynecologists, and associated physicians with minimally invasive, localized, diagnostic, and therapeutic interventions for a wide range of urologic and gynecologic procedures. Our innovative portfolio of products offers the physician a safe, efficient, and precise approach to accessing, imaging, and measuring a wide range of challenging anatomies and pathologies as well as expanding their diagnostic and therapeutic capabilities. In addition to these benefits to the physician, Sanovas is extremely sensitive to optimizing patient care and outcome. As a result, each product is designed with the objective that each patient regardless of surgical or procedural site, will promote reduced diagnostic/operative time, minimized pain, and accelerated recovery time. Lastly, Sanovas has created an economic model where the cost of acquisition, usage, and disposal ultimately lowers the cost of delivery of healthcare. These benefits are made possible by the groundbreaking designs Sanovas Interventional has developed for the Urology & Gynecology specialties as described below.

  • Simple, high-quality, and miniaturized visualization platform.

  • User-friendly instrumentation design.

  • Turn-key, kit-based product offering.

  • Interchangeable and universal equipment configurations.

FDA REGULATORY DISCLOSURE:
Sanovas Inc. is an emerging technology company. These products are investigational medical devices that have not been approved or cleared for use in the United States.